US Stock MarketDetailed Quotes
APDN Applied DNA Sciences
- 4.370
- -0.630-12.60%
Close Apr 26 16:00 ET
- 4.330
- -0.040-0.92%
Post 18:45 ET
3.77MMarket Cap-397P/E (TTM)
4.920High4.100Low84.08KVolume4.810Open5.000Pre Close377.94KTurnover12.11%Turnover RatioLossP/E (Static)863.07KShares37.20052wk High0.89P/B3.03MFloat Cap4.07052wk Low--Dividend TTM694.04KShs Float719999.520Historical High--Div YieldTTM16.40%Amplitude4.070Historical Low4.495Avg Price1Lot Size
Applied DNA Sciences Key Stats
Quarterly+Annual
YOY
| (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | (Q3)Jun 30, 2022 | (Q2)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -57.68%-3.76M | 30.74%-6.22M | 17.76%-2.68M | 21.95%-1.37M | 181.86%214.39K | 35.62%-2.38M | 32.95%-8.98M | 30.85%-3.26M | -40.36%-1.75M | 91.99%-261.89K |
| Net income from continuing operations | 70.60%-1.13M | -21.20%-10.02M | -444.07%-3.62M | -176.87%-3.11M | 131.32%551.18K | 18.57%-3.84M | 42.08%-8.27M | 85.26%-664.55K | 67.37%-1.12M | -16.00%-1.76M |
| Operating gains losses | -200.28%-2.64M | 88.38%-860.48K | 89.32%-519.7K | 115.83%278.4K | ---3.25M | --2.63M | -747.83%-7.41M | -2,431.25%-4.87M | ---1.76M | ---- |
| Depreciation and amortization | -11.79%298.95K | 5.56%1.36M | 0.61%329.68K | 8.71%349.15K | 7.37%344.5K | 5.66%338.92K | 52.82%1.29M | 9.27%327.68K | 29.63%321.19K | 60.93%320.86K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | --1.67M | ---- | ---- | ---- |
| Change In working capital | 52.17%-628.05K | 156.31%2.45M | 401.01%767.6K | 27.43%681.25K | 37.02%2.31M | -29.81%-1.31M | 126.40%954.57K | 84.00%-255K | -65.56%534.59K | 194.67%1.69M |
| -Change in receivables | 71.94%-195.25K | 672.48%3.05M | 187.68%410.39K | 561.30%1.25M | 64.30%2.09M | 34.55%-695.91K | 79.80%-532.96K | 77.60%-468.03K | -118.54%-271.16K | 208.34%1.27M |
| -Change in inventory | -137.74%-47.26K | -64.54%272.22K | -12.60%-53.61K | 0.37%89.66K | -83.11%110.93K | 80.70%125.23K | 187.98%767.69K | 94.94%-47.61K | -69.35%89.33K | 470.84%656.66K |
| -Change in prepaid assets | -110.28%-13.71K | 255.67%767.81K | 23.08%135.66K | -2.10%233.63K | 132.42%265.15K | 649.59%133.37K | -1,721.63%-493.22K | 151.88%110.22K | 3.85%238.63K | -706.05%-817.8K |
| -Change in payables and accrued expense | 34.60%-383.42K | -245.23%-1.35M | -18.46%280.6K | -875.52%-885.47K | -124.95%-160.26K | -244.86%-586.24K | 882.46%930.5K | -78.76%344.12K | 134.14%114.18K | 216.15%642.19K |
| -Change in other working capital | 104.00%11.6K | -203.74%-293.12K | 97.19%-5.45K | -102.04%-7.41K | 114.74%9.42K | -264.09%-289.68K | 222.83%282.56K | -787.07%-193.71K | 473.89%363.61K | -332.39%-63.88K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -57.68%-3.76M | 30.74%-6.22M | 17.76%-2.68M | 21.95%-1.37M | 181.86%214.39K | 35.62%-2.38M | 32.95%-8.98M | 30.85%-3.26M | -40.36%-1.75M | 91.99%-261.89K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -123.84%-1.1M | -281.05%-924.67K | -111.02%-161.8K | 17.08%-54.34K | 142.99%45K | 80.79%-489.55K | 73.23%-242.66K | 84.75%-76.68K | 91.91%-65.53K |
| Net PPE purchase and sale | --0 | 93.17%-33.45K | 100.04%87 | 68.44%-24.2K | 17.08%-54.34K | 142.99%45K | 80.79%-489.55K | 73.23%-242.66K | 84.75%-76.68K | 91.91%-65.53K |
| Net business purchase and sale | ---- | ---1.06M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | -123.84%-1.1M | -281.05%-924.67K | -111.02%-161.8K | 17.08%-54.34K | 142.99%45K | 80.79%-489.55K | 73.23%-242.66K | 84.75%-76.68K | 91.91%-65.53K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -35.08K | 0 | 0 | 0 | 0 | 0 | 23.27%18.13M | 14.03M | 75 | |
| Net common stock issuance | --45.57K | --0 | --0 | --0 | --0 | --0 | 4.87%14.43M | --10.33M | --0 | ---- |
| Proceeds from stock option exercised by employees | ---- | --0 | --0 | ---- | ---- | ---- | 41.55%3.7M | --3.7M | ---- | ---- |
| Net other financing activities | ---80.64K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---35.08K | --0 | --0 | --0 | --0 | --0 | 23.27%18.13M | --14.03M | --75 | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | -48.07%7.9M | 132.12%15.22M | 145.76%11.51M | 100.18%13.04M | 368.54%12.88M | 132.12%15.22M | -15.82%6.55M | -61.54%4.68M | -53.23%6.51M | -35.20%2.75M |
| Current changes in cash | -62.21%-3.79M | -184.45%-7.31M | -134.22%-3.6M | 16.38%-1.53M | -95.75%160.05K | 38.58%-2.34M | 803.07%8.66M | 287.48%10.53M | -4.47%-1.83M | -61.13%3.76M |
| End cash Position | -68.09%4.11M | -48.07%7.9M | -48.07%7.9M | 145.76%11.51M | 100.18%13.04M | 368.54%12.88M | 132.12%15.22M | 132.12%15.22M | -61.54%4.68M | -53.23%6.51M |
| Free cash flow | -57.68%-3.76M | 33.49%-6.3M | 27.40%-2.54M | 16.38%-1.53M | 148.88%160.05K | 37.40%-2.38M | 40.60%-9.47M | 37.68%-3.5M | -4.48%-1.83M | 91.98%-327.42K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg